Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.12
-0.0200-1.75%
Volume:5K
Turnover:5.15K
Market Cap:16.96M
PE:-1.51
High:1.13
Open:1.13
Low:1.12
Close:1.14
52wk High:2.29
52wk Low:0.7500
Shares:15.14M
Float Shares:12.12M
Volume Ratio:0.80
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:6.28
PE(LYR):-0.91

Loading ...

BioCardia Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview

Reuters
·
Aug 11

BioCardia Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview

Reuters
·
Aug 07

BioCardia Schedules Q2 Financial Results Conference Call

Reuters
·
Aug 06

BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026

GlobeNewswire
·
Aug 06

BioCardia CEO Peter Altman Acquires 5,000 Common Shares Valued at $3,900

Reuters
·
Jul 30

Biocardia CEO Peter Altman Buys $415 of Common Stock

Reuters
·
Jul 21

Biocardia CEO Peter Altman Acquires Common Shares Worth $3,749.80

Reuters
·
Jul 16

Biocardia CEO Peter Altman Acquires $7,175 of Common Shares

Reuters
·
Jul 11

Biocardia CEO Peter Altman Acquires 5,400 Common Shares Worth $5,208.30

Reuters
·
Jul 09

BioCardia Director Makes Bold Move With Fresh Insider Buy

TIPRANKS
·
Jun 25

Biocardia Director Simon H. Stertzer Acquires 109,200 Common Shares Valued at $103,584

Reuters
·
Jun 25

BioCardia CEO Peter Altman acquires USD 2,043 of common shares

Reuters
·
Jun 22

BioCardia issues letter to shareholders on 2026 priorities

TIPRANKS
·
Jun 18

BioCardia Outlines 2026 CardiAMP Strategy and Milestones

TIPRANKS
·
Jun 18

BioCardia targets Q4 2026 Japan PMDA filing for CardiAMP cell therapy approval

Reuters
·
Jun 18

BioCardia publishes 2026 shareholder letter outlining priorities, strategic opportunities

Reuters
·
Jun 18

BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities

THOMSON REUTERS
·
Jun 18

BioCardia wins Nasdaq extension to Oct. 7 to meet $2.5 million equity rule

Reuters
·
Jun 12

BioCardia CEO Peter Altman acquires 5,000 common shares valued at $4,250

Reuters
·
Jun 10

BioCardia Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 09